Group 1 - The company has signed a guarantee contract with China Minsheng Bank to provide an irrevocable joint liability guarantee for its wholly-owned subsidiary, Hunan Warner Dajian Pharmaceutical Zhi Gen Pharmaceutical Co., Ltd., for a loan amount of 700 million yuan [2][10] - The guarantee covers the principal, interest, penalties, compound interest, default fines, compensation for damages, and costs related to the realization of creditor and guarantee rights [2][9] - The guarantee period is one year from the expiration of the subsidiary's debt obligations, with specific conditions for installment repayments [2][9] Group 2 - The company held a board meeting on March 7, 2025, to approve the proposal for the expected external guarantee limit for 2025, which was subsequently approved at the annual shareholders' meeting on May 12, 2025 [3][4] - The total guarantee amount approved for 2025 is capped at 800 million yuan, which can be used for various financing needs of the subsidiary [5] - The authorization for the guarantee limit is valid until the next shareholders' meeting, allowing for repeated use within the approved limit [5] Group 3 - As of the announcement date, the total external guarantee amount provided by the company and its subsidiaries is 700 million yuan, which includes the current guarantee, and there are no overdue guarantees [10] - The guarantees provided are entirely for the company's wholly-owned subsidiary, representing 38.82% of the company's audited net assets attributable to shareholders as of the end of 2024 [10]
湖南华纳大药厂股份有限公司关于为全资孙公司提供担保的进展公告